Cell Source

New York, United States

Cell Source focuses on developing cell therapy treatments based on the management of immune tolerance.

$1.5M raised

Jan 2026

Post-IPO Debt

30,000+ verified contacts

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Cell Source

How much funding has Cell Source raised?

Cell Source has raised $1.5M in total funding. The most recent round was Post-IPO Debt. The last funding was announced in January 2026.

Where is Cell Source headquartered?

Cell Source is headquartered in New York, United States.

What does Cell Source do?

Cell Source focuses on developing cell therapy treatments based on the management of immune tolerance.

What stage is Cell Source at?

Cell Source is at the Post-IPO Debt stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated January 15, 2026.

MLA

"Cell Source — Funding & Investors." VCBacked, January 15, 2026, https://www.vcbacked.co/company/cell-source. Accessed July 3, 2026.

APA

VCBacked. (2026). Cell Source — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/cell-source

Wikipedia (cite web)

{{cite web |title=Cell Source — Funding & Investors |url=https://www.vcbacked.co/company/cell-source |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated January 15, 2026.